Kolmar BioTech

215380 · KOSDAQ · ₩215380 · 콜마바이오텍

₩2,125▼ ₩15 (0.70%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩38B₩43B₩39B₩47B₩31B
Cost of sales₩27B₩31B₩32B₩40B₩25B
Gross profit₩10B₩13B₩6.3B₩6.7B₩5.9B
Operating income−₩3.9B₩1.8B−₩4.5B−₩2.5B−₩3.5B
Net income−₩5.5B₩225M−₩5.1B−₩1.9B−₩1.9B
Net income to shareholders−₩5.5B₩225M−₩5.1B−₩1.9B−₩1.9B

Balance sheet

20252024202320222021
Total assets₩87B₩95B₩98B₩95B₩100B
Current assets₩17B₩20B₩20B₩14B₩25B
Cash and equivalents₩3.8B₩4B₩5.4B₩3.6B₩455M
Total liabilities₩63B₩65B₩76B₩65B₩69B
Current liabilities₩30B₩31B₩46B₩45B₩38B
Borrowings₩50B₩51B₩51B₩40B₩38B
Total equity₩23B₩29B₩22B₩30B₩31B
Shareholders' equity₩23B₩29B₩22B₩30B₩31B

Cash flow

20252024202320222021
Cash from operations−₩630M−₩1.1B−₩3.2B₩2.5B₩1.7B
Capital spending₩254M₩292M₩836M₩11B₩37B
Free cash flow−₩884M−₩1.4B−₩4.1B−₩8.9B−₩35B

Consolidated where available. Amounts in won.

Also known as: Kolmar BioTech / 콜마바이오텍 / 215380 / KRX:215380

Source: KRX statistical information